User login
The National Organization for Rare Disorders (NORD) has posted requests for proposals (RFPs) for grants to support research on several rare diseases. July 31, 2015, will be the deadline to submit abstracts and letters of intent. The RFPs are posted on the NORD website (www.rarediseases.org). Diseases for which funding is available in this cycle are: alveolar capillary dysplasia, autoimmune polyglandular syndrome type 1, pseudomyxoma peritonei, cat eye syndrome, Creutzfeldt-Jakob disease, homocystinuria due to cystathionine beta synthase deficiency, lysosomal storage diseases, and complement-related diseases. All decisions regarding funding are made by the NORD Scientific and Medical Advisory Committee. Questions may be directed to jkraska@rarediseases.org.
The National Organization for Rare Disorders (NORD) has posted requests for proposals (RFPs) for grants to support research on several rare diseases. July 31, 2015, will be the deadline to submit abstracts and letters of intent. The RFPs are posted on the NORD website (www.rarediseases.org). Diseases for which funding is available in this cycle are: alveolar capillary dysplasia, autoimmune polyglandular syndrome type 1, pseudomyxoma peritonei, cat eye syndrome, Creutzfeldt-Jakob disease, homocystinuria due to cystathionine beta synthase deficiency, lysosomal storage diseases, and complement-related diseases. All decisions regarding funding are made by the NORD Scientific and Medical Advisory Committee. Questions may be directed to jkraska@rarediseases.org.
The National Organization for Rare Disorders (NORD) has posted requests for proposals (RFPs) for grants to support research on several rare diseases. July 31, 2015, will be the deadline to submit abstracts and letters of intent. The RFPs are posted on the NORD website (www.rarediseases.org). Diseases for which funding is available in this cycle are: alveolar capillary dysplasia, autoimmune polyglandular syndrome type 1, pseudomyxoma peritonei, cat eye syndrome, Creutzfeldt-Jakob disease, homocystinuria due to cystathionine beta synthase deficiency, lysosomal storage diseases, and complement-related diseases. All decisions regarding funding are made by the NORD Scientific and Medical Advisory Committee. Questions may be directed to jkraska@rarediseases.org.
